4//SEC Filing
DeAngelis Kiernan Thomas 4
Accession 0001104659-21-110529
CIK 0001818382other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:10 PM ET
Size
8.9 KB
Accession
0001104659-21-110529
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
DeAngelis Kiernan Thomas
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2021-08-26+99,576→ 99,576 totalExercise: $8.49Exp: 2030-06-11→ Common Stock (99,576 underlying) - Award
Stock Options (right to buy)
2021-08-26+1,575→ 1,575 totalExercise: $10.28From: 2021-12-14Exp: 2030-12-14→ Common Stock (1,575 underlying)
Footnotes (3)
- [F1]The first 1/3 of the grant, for 33,192 shares, is vested and exercisable. The next 1/3 of the grant will vest on April 20, 2022 and the final 1/3 will vest on April 20, 2023.
- [F2]On August 26, 2021, Alpha Healthcare Acquisition Corp. ("AHAC") consummated a business combination (the "Business Combination") by and among AHAC, Hunter Merger Sub, Inc., a Delaware corporation ("Hunter Merger Sub") and Humacyte, Inc., a Delaware corporation ("Legacy Humacyte"), AHAC changed its name to "Humacyte, Inc." and Hunter Merger Sub merged with and into Legacy Humacyte. As part of the Business Combination, each Legacy Humacyte stock option was exchanged for a stock option to acquire 0.2626 shares of common stock of Humacyte, Inc.
- [F3]Options to purchase 2,625 shares of Common Stock granted on 12/14/2020, which vest as follows: (i) one-fifth on the first anniversary of the vesting commencement date, (ii) two-fifths in equal installments over a period of 24 months commencing on the first anniversary of the vesting commencement date, (iii) one-fifth upon the submission of a Biologics License Application to the FDA and (iv) one-fifth upon FDA approval of one of Humacyte's product candidates. Accordingly, columns 5, 7, and 9 of Table II report the number of securities equal to three-fifths of the 12/14/2020 option grant.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001877848
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 4:10 PM ET
- Size
- 8.9 KB